Home > Insider Trading > Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc. (ARWR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Is ARWR A Good Stock To Buy Now According To Hedge Funds?

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...

Keep Reading →

December 19th, 2020 - Hedge Funds News

Hedge Fund and Insider Trading News: Mike Novogratz, Crispin Odey, Steve Cohen, Fulcrum Asset Management, Elliott Management, Envestnet Inc (ENV), Arrowhead Pharmaceuticals Inc (ARWR), and More

Bitcoin is like "digital gold" and won't be used in the same way as traditional currency for at least the next five years, billionaire investor Mike Novogratz told Bloomberg on Friday.

Keep Reading →

October 26th, 2020 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Ray Dalio, Balyasny Asset Management, Asia Research and Capital Management, Alcur Select, Lam Research Corporation (LRCX), Enghouse Systems Limited (EGHSF), and More

Bridgewater Associates founder Ray Dalio is giving $50 million to NewYork-Presbyterian to fight health inequality at a time when the coronavirus pandemic has laid bare the disproportionate access to health...

Keep Reading →

October 14th, 2020 - Hedge Funds Insider Trading

Arrowhead Pharmaceuticals Inc. (ARWR) Fell Out Of Favor With Hedge Funds

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

October 6th, 2020 - Hedge Funds News

Did Hedge Funds Make The Right Call On Arrowhead Pharmaceuticals Inc. (ARWR) ?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).

Keep Reading →

July 18th, 2020 - Hedge Funds News

Is Arrowhead Pharmaceuticals Inc. (ARWR) A Good Stock To Buy?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

June 16th, 2020 - Hedge Funds News

Hedge Funds Have Never Been This Bullish On Arrowhead Pharmaceuticals, Inc. (ARWR)

Coronavirus is probably the #1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW.

Keep Reading →

March 20th, 2020 - Hedge Funds News

Did Hedge Funds Drop The Ball On Arrowhead Research Corp (ARWR) ?

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their...

Keep Reading →

December 11th, 2019 - Hedge Funds News

Hedge Funds Have Never Been More Bullish On Arrowhead Pharmaceuticals, Inc. (ARWR)

Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.

Keep Reading →

October 23rd, 2019 - Hedge Funds News

Hedge Fund and Insider Trading News: Ken Griffin, Tom Steyer, Amber Capital, Acadia Pharmaceuticals Inc. (ACAD), and More

PARIS (Reuters) - Activist shareholder Amber Capital, which is being sued by Lagardere (LAGA.PA), said on Monday the lawsuit was baseless and it would continue to seek strategy and management changes ...

Keep Reading →

October 14th, 2019 - Hedge Funds Insider Trading